Johnson & Johnson has announced a proposed settlement of $5.5 billion aimed at resolving a massive wave of litigation regarding its talcum powder products. For years, the company has faced thousands of lawsuits from plaintiffs who allege that the company's talc-based products were contaminated with asbestos, leading to cases of ovarian cancer and mesothelioma.

The company has consistently denied these allegations, maintaining that its products are safe and do not contain asbestos. Despite these denials, the legal costs and reputational damage have persisted for over a decade. This latest proposal represents a significant effort by the firm to move past the litigation, which has been a major source of uncertainty for investors and a primary focus of consumer safety advocates.

While the company views this settlement as a path toward closure, the proposal remains subject to legal hurdles, including approval from the courts and the participation of a sufficient number of plaintiffs. The legal battle has been complex, involving multiple attempts by the company to utilize bankruptcy filings to manage the claims—a strategy that has faced significant pushback from victims' groups and legal experts. As it stands, the $5.5 billion figure is the latest attempt to reach a global resolution that would effectively end the ongoing courtroom disputes.